il18r1 Search Results


95
Thermo Fisher gene exp il18r1 hs00175381 m1
Gene Exp Il18r1 Hs00175381 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/Gene+Exp%2E+IL18R1%2C+Hs00175381_m1/pm33239358-83-14--1
Average 95 stars, based on 1 article reviews
gene exp il18r1 hs00175381 m1 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

93
Sino Biological il 18rβ ecd
Il 18rβ Ecd, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/Human+IL18R1+%2F+CD218a+Protein/pmc12452691-156-16-29
Average 93 stars, based on 1 article reviews
il 18rβ ecd - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Miltenyi Biotec fitc anti cd218a
Fitc Anti Cd218a, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/CD218a+(IL-18R%CE%B1)+Antibody%2C+anti-mouse%2C+REAfinity/pm36171284-606-218-223
Average 93 stars, based on 1 article reviews
fitc anti cd218a - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Miltenyi Biotec mouse monoclonal anti cd218 il 18rα pe vio770 conjugated

Mouse Monoclonal Anti Cd218 Il 18rα Pe Vio770 Conjugated, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/CD218+(IL-18R%CE%B1)+Antibody%2C+anti-human/pmc10014287-38-0-9
Average 90 stars, based on 1 article reviews
mouse monoclonal anti cd218 il 18rα pe vio770 conjugated - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Cyagen Biosciences c57bl 6j il18r1
FIGURE 6 | ILC development in the absence of IL18Ra signaling. (A) Numbers of BM progenitors and ILC2 from <t>Il18r1+/+</t> and Il18r1-/- mice. (B) Representative FACS plot showing the expression of PD-1 in Flt3-aLP from Il18r1+/+ and Il18r1-/- BM. (C) Percentage of PD-1+ in aLP from Il18r1+/+ and Il18r1-/- mice. (D, E) Numbers of B cells, CD4+ T cells, CD8+ T cells, NK cells, and ILC1s in the spleen and liver from Il18r1+/+ and Il18r1-/- mice. (F) Number of total T1ST2+ ILC2 and activated T1ST2+KLRG1+ ILC2 in the lung of Il18r1+/+ and Il18r1-/- mice. (G–I) Percentage of ILC2 and ILC3 in mesenteric lymph nodes, small intestine, and large intestine from I Il18r1+/+ and Il18r1-/- mice. (J) Cell expansion of Il18r1+/+ and Il18r1-/- BM CLP (50~200 cells) and aLP (100~300 cells) after culture on OP9-DL1 with 20 ng/ml SCF and 20 ng/ml IL-7 for 14 days. (K) Reconstitution of lymphoid cell compartment in Rag2-/-Il2rg-/- mice adoptively transferred with Il18r1+/+ and Il18r1-/-
C57bl 6j Il18r1, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/Il18r1/pm35874724-203-11-17
Average 93 stars, based on 1 article reviews
c57bl 6j il18r1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Novus Biologicals rabbit anti il18r1
FIGURE 6 | ILC development in the absence of IL18Ra signaling. (A) Numbers of BM progenitors and ILC2 from <t>Il18r1+/+</t> and Il18r1-/- mice. (B) Representative FACS plot showing the expression of PD-1 in Flt3-aLP from Il18r1+/+ and Il18r1-/- BM. (C) Percentage of PD-1+ in aLP from Il18r1+/+ and Il18r1-/- mice. (D, E) Numbers of B cells, CD4+ T cells, CD8+ T cells, NK cells, and ILC1s in the spleen and liver from Il18r1+/+ and Il18r1-/- mice. (F) Number of total T1ST2+ ILC2 and activated T1ST2+KLRG1+ ILC2 in the lung of Il18r1+/+ and Il18r1-/- mice. (G–I) Percentage of ILC2 and ILC3 in mesenteric lymph nodes, small intestine, and large intestine from I Il18r1+/+ and Il18r1-/- mice. (J) Cell expansion of Il18r1+/+ and Il18r1-/- BM CLP (50~200 cells) and aLP (100~300 cells) after culture on OP9-DL1 with 20 ng/ml SCF and 20 ng/ml IL-7 for 14 days. (K) Reconstitution of lymphoid cell compartment in Rag2-/-Il2rg-/- mice adoptively transferred with Il18r1+/+ and Il18r1-/-
Rabbit Anti Il18r1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/IL18R1+Antibody/pm35201443-37-23-26
Average 90 stars, based on 1 article reviews
rabbit anti il18r1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
OriGene human il 18rα
FIGURE 6 | ILC development in the absence of IL18Ra signaling. (A) Numbers of BM progenitors and ILC2 from <t>Il18r1+/+</t> and Il18r1-/- mice. (B) Representative FACS plot showing the expression of PD-1 in Flt3-aLP from Il18r1+/+ and Il18r1-/- BM. (C) Percentage of PD-1+ in aLP from Il18r1+/+ and Il18r1-/- mice. (D, E) Numbers of B cells, CD4+ T cells, CD8+ T cells, NK cells, and ILC1s in the spleen and liver from Il18r1+/+ and Il18r1-/- mice. (F) Number of total T1ST2+ ILC2 and activated T1ST2+KLRG1+ ILC2 in the lung of Il18r1+/+ and Il18r1-/- mice. (G–I) Percentage of ILC2 and ILC3 in mesenteric lymph nodes, small intestine, and large intestine from I Il18r1+/+ and Il18r1-/- mice. (J) Cell expansion of Il18r1+/+ and Il18r1-/- BM CLP (50~200 cells) and aLP (100~300 cells) after culture on OP9-DL1 with 20 ng/ml SCF and 20 ng/ml IL-7 for 14 days. (K) Reconstitution of lymphoid cell compartment in Rag2-/-Il2rg-/- mice adoptively transferred with Il18r1+/+ and Il18r1-/-
Human Il 18rα, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/IL18R1+(NM_003855)+Human+Untagged+Clone/pmc03714795-199-7-22
Average 90 stars, based on 1 article reviews
human il 18rα - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

91
R&D Systems human il18 elisa kit
FIGURE 6 | ILC development in the absence of IL18Ra signaling. (A) Numbers of BM progenitors and ILC2 from <t>Il18r1+/+</t> and Il18r1-/- mice. (B) Representative FACS plot showing the expression of PD-1 in Flt3-aLP from Il18r1+/+ and Il18r1-/- BM. (C) Percentage of PD-1+ in aLP from Il18r1+/+ and Il18r1-/- mice. (D, E) Numbers of B cells, CD4+ T cells, CD8+ T cells, NK cells, and ILC1s in the spleen and liver from Il18r1+/+ and Il18r1-/- mice. (F) Number of total T1ST2+ ILC2 and activated T1ST2+KLRG1+ ILC2 in the lung of Il18r1+/+ and Il18r1-/- mice. (G–I) Percentage of ILC2 and ILC3 in mesenteric lymph nodes, small intestine, and large intestine from I Il18r1+/+ and Il18r1-/- mice. (J) Cell expansion of Il18r1+/+ and Il18r1-/- BM CLP (50~200 cells) and aLP (100~300 cells) after culture on OP9-DL1 with 20 ng/ml SCF and 20 ng/ml IL-7 for 14 days. (K) Reconstitution of lymphoid cell compartment in Rag2-/-Il2rg-/- mice adoptively transferred with Il18r1+/+ and Il18r1-/-
Human Il18 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/Human+IL18R1+ELISA+Kit+(Colorimetric)/10__1165_slash_rcmb__2017___0290oc-488-17-21
Average 91 stars, based on 1 article reviews
human il18 elisa kit - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

86
Jackson Laboratory il18r1
a , Thymus supernatants generated from female 1-2 mo C57BL/6 mice given SL-TBI (550 cGy), Dexamethasone (i.p., 20 mg/kg), Cyclophosphamide (i.p., 200 mg/kg) or LPS (i.p., 1.5 mg/kg) and mature Caspase-1 assayed by ELISA on days 0 (n = 4), 0.5 (n = 3), 1 (n = 3) and 3 (n = 3). b , Female 1-2 mo C57BL/6 WT (d0, n = 18; day 3, n = 15) or Il18 −/− (d0, n = 9; day 3, n = 8) and <t>Il18r1</t> −/− (d0, n = 10; d3, n = 5) mice were given SL-TBI and thymus cellularity was assessed at baseline (day 0) or 3 days post-SL-TBI. c , Thymus supernatants generated from female 1-2 mo C57BL/6 WT (d0, n = 5; d1, n = 8; d3, n = 3) and Il18 −/− (n = 4/group) mice given SL-TBI (550 cGy) and Cortisol assayed by ELISA on days 0, 1 and 3. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for a using one-way ANOVA with Dunnet’s correction for multiple comparisons, b using Tukey’s correction for multiple comparisons, and for c using an unpaired two-tailed t-test. Panel a icons created with BioRender.com .
Il18r1, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/il18r1/pmc12479347-225-39-20
Average 86 stars, based on 1 article reviews
il18r1 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

93
Thermo Fisher gene exp il18r1 hs00977691 m1
a , Thymus supernatants generated from female 1-2 mo C57BL/6 mice given SL-TBI (550 cGy), Dexamethasone (i.p., 20 mg/kg), Cyclophosphamide (i.p., 200 mg/kg) or LPS (i.p., 1.5 mg/kg) and mature Caspase-1 assayed by ELISA on days 0 (n = 4), 0.5 (n = 3), 1 (n = 3) and 3 (n = 3). b , Female 1-2 mo C57BL/6 WT (d0, n = 18; day 3, n = 15) or Il18 −/− (d0, n = 9; day 3, n = 8) and <t>Il18r1</t> −/− (d0, n = 10; d3, n = 5) mice were given SL-TBI and thymus cellularity was assessed at baseline (day 0) or 3 days post-SL-TBI. c , Thymus supernatants generated from female 1-2 mo C57BL/6 WT (d0, n = 5; d1, n = 8; d3, n = 3) and Il18 −/− (n = 4/group) mice given SL-TBI (550 cGy) and Cortisol assayed by ELISA on days 0, 1 and 3. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for a using one-way ANOVA with Dunnet’s correction for multiple comparisons, b using Tukey’s correction for multiple comparisons, and for c using an unpaired two-tailed t-test. Panel a icons created with BioRender.com .
Gene Exp Il18r1 Hs00977691 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/Gene+Exp%2E+IL18R1%2C+Hs00977691_m1/pmc10958000-187-28-45
Average 93 stars, based on 1 article reviews
gene exp il18r1 hs00977691 m1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Thermo Fisher snp il18r1 c 1226146 10
a , Thymus supernatants generated from female 1-2 mo C57BL/6 mice given SL-TBI (550 cGy), Dexamethasone (i.p., 20 mg/kg), Cyclophosphamide (i.p., 200 mg/kg) or LPS (i.p., 1.5 mg/kg) and mature Caspase-1 assayed by ELISA on days 0 (n = 4), 0.5 (n = 3), 1 (n = 3) and 3 (n = 3). b , Female 1-2 mo C57BL/6 WT (d0, n = 18; day 3, n = 15) or Il18 −/− (d0, n = 9; day 3, n = 8) and <t>Il18r1</t> −/− (d0, n = 10; d3, n = 5) mice were given SL-TBI and thymus cellularity was assessed at baseline (day 0) or 3 days post-SL-TBI. c , Thymus supernatants generated from female 1-2 mo C57BL/6 WT (d0, n = 5; d1, n = 8; d3, n = 3) and Il18 −/− (n = 4/group) mice given SL-TBI (550 cGy) and Cortisol assayed by ELISA on days 0, 1 and 3. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for a using one-way ANOVA with Dunnet’s correction for multiple comparisons, b using Tukey’s correction for multiple comparisons, and for c using an unpaired two-tailed t-test. Panel a icons created with BioRender.com .
Snp Il18r1 C 1226146 10, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/SNP+IL18R1%2C+C___1226146_10/pmc10154240-280-61-73
Average 94 stars, based on 1 article reviews
snp il18r1 c 1226146 10 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

91
Boster Bio il18r1
Identification of IL17RB, <t>IL18R1,</t> and IL22RA2 as potential targets of miR-155-5p. IL17RB, IL18R1, and IL22RA2 were identified as potential targets of miR-155-5p by the databases (a); this was confirmed by the dual-luciferase report assay (b). The levels of IL17RB, IL18R1, and IL22RA2 were measured by qRT-PCR (c). *p < 0.05 and **p < 0.01, ANOVA.
Il18r1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il18r1/Human+IL-18R1+ELISA+Kit+PicoKine/pmc09276023-47-20-38
Average 91 stars, based on 1 article reviews
il18r1 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

Image Search Results


Journal: iScience

Article Title: Phenotypic and functional characterization of pharmacologically expanded Vγ9Vδ2 T cells in pigtail macaques

doi: 10.1016/j.isci.2023.106269

Figure Lengend Snippet:

Article Snippet: Mouse monoclonal anti-CD218 (IL-18Rα) PE-Vio770 conjugated (clone: H44) , Miltenyi Biotec , Cat# 130-101-723; RRID: AB_2656352.

Techniques: Recombinant, Staining, Random Hexamer, Conjugation Assay, Reverse Transcription, Software, Sequencing

FIGURE 6 | ILC development in the absence of IL18Ra signaling. (A) Numbers of BM progenitors and ILC2 from Il18r1+/+ and Il18r1-/- mice. (B) Representative FACS plot showing the expression of PD-1 in Flt3-aLP from Il18r1+/+ and Il18r1-/- BM. (C) Percentage of PD-1+ in aLP from Il18r1+/+ and Il18r1-/- mice. (D, E) Numbers of B cells, CD4+ T cells, CD8+ T cells, NK cells, and ILC1s in the spleen and liver from Il18r1+/+ and Il18r1-/- mice. (F) Number of total T1ST2+ ILC2 and activated T1ST2+KLRG1+ ILC2 in the lung of Il18r1+/+ and Il18r1-/- mice. (G–I) Percentage of ILC2 and ILC3 in mesenteric lymph nodes, small intestine, and large intestine from I Il18r1+/+ and Il18r1-/- mice. (J) Cell expansion of Il18r1+/+ and Il18r1-/- BM CLP (50~200 cells) and aLP (100~300 cells) after culture on OP9-DL1 with 20 ng/ml SCF and 20 ng/ml IL-7 for 14 days. (K) Reconstitution of lymphoid cell compartment in Rag2-/-Il2rg-/- mice adoptively transferred with Il18r1+/+ and Il18r1-/-

Journal: Frontiers in immunology

Article Title: IL-18/IL-18R Signaling Is Dispensable for ILC Development But Constrains the Growth of ILCP/ILCs.

doi: 10.3389/fimmu.2022.923424

Figure Lengend Snippet: FIGURE 6 | ILC development in the absence of IL18Ra signaling. (A) Numbers of BM progenitors and ILC2 from Il18r1+/+ and Il18r1-/- mice. (B) Representative FACS plot showing the expression of PD-1 in Flt3-aLP from Il18r1+/+ and Il18r1-/- BM. (C) Percentage of PD-1+ in aLP from Il18r1+/+ and Il18r1-/- mice. (D, E) Numbers of B cells, CD4+ T cells, CD8+ T cells, NK cells, and ILC1s in the spleen and liver from Il18r1+/+ and Il18r1-/- mice. (F) Number of total T1ST2+ ILC2 and activated T1ST2+KLRG1+ ILC2 in the lung of Il18r1+/+ and Il18r1-/- mice. (G–I) Percentage of ILC2 and ILC3 in mesenteric lymph nodes, small intestine, and large intestine from I Il18r1+/+ and Il18r1-/- mice. (J) Cell expansion of Il18r1+/+ and Il18r1-/- BM CLP (50~200 cells) and aLP (100~300 cells) after culture on OP9-DL1 with 20 ng/ml SCF and 20 ng/ml IL-7 for 14 days. (K) Reconstitution of lymphoid cell compartment in Rag2-/-Il2rg-/- mice adoptively transferred with Il18r1+/+ and Il18r1-/-

Article Snippet: C57BL/6J mice were purchased from Shanghai Lab Animal Research Centre, while C57BL/6J Il18r1-/- mice were purchased from Cyagen Biosciences.

Techniques: Expressing

FIGURE 7 | IL-18 suppresses the growth of ILCP/ILCs. Lin-ST2-PD1+IL-18Ra+ cells (350~700 cells) were FACS-sorted from Il18r1+/+ and Il18r1-/- BM and cultured on OP9-DL1 in the presence of SCF (20 ng/ml) and IL-7 (20 ng/ml) with or without IL-18 for 7 days. (A) Representative FACS plot showing NK/ILC1, ILC2, and ILC3 generated from the culture. (B, C) Percentage of the NK/ILC1, ILC2, and ILC3 in CD45+ cells from the culture. (D) Mean fluorescence intensity of EOMES and NK1.1 in GATA3-RORgt- cells. (E) Expansion fold of the cultured cells. (F) Percentage of Ki67+ cells in the indicated cell populations. (G–I) Representative FACS plot and statistical analysis showing the percentage of Annexin V+PI- (H) and Annexin V+PI+ (I) cells in CD45+ cells from the culture. Data are representative of two independent experiments with three mice in each group. The data were presented as mean ± SEM, analyzed by two-tailed Student’s t-test. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Journal: Frontiers in immunology

Article Title: IL-18/IL-18R Signaling Is Dispensable for ILC Development But Constrains the Growth of ILCP/ILCs.

doi: 10.3389/fimmu.2022.923424

Figure Lengend Snippet: FIGURE 7 | IL-18 suppresses the growth of ILCP/ILCs. Lin-ST2-PD1+IL-18Ra+ cells (350~700 cells) were FACS-sorted from Il18r1+/+ and Il18r1-/- BM and cultured on OP9-DL1 in the presence of SCF (20 ng/ml) and IL-7 (20 ng/ml) with or without IL-18 for 7 days. (A) Representative FACS plot showing NK/ILC1, ILC2, and ILC3 generated from the culture. (B, C) Percentage of the NK/ILC1, ILC2, and ILC3 in CD45+ cells from the culture. (D) Mean fluorescence intensity of EOMES and NK1.1 in GATA3-RORgt- cells. (E) Expansion fold of the cultured cells. (F) Percentage of Ki67+ cells in the indicated cell populations. (G–I) Representative FACS plot and statistical analysis showing the percentage of Annexin V+PI- (H) and Annexin V+PI+ (I) cells in CD45+ cells from the culture. Data are representative of two independent experiments with three mice in each group. The data were presented as mean ± SEM, analyzed by two-tailed Student’s t-test. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.

Article Snippet: C57BL/6J mice were purchased from Shanghai Lab Animal Research Centre, while C57BL/6J Il18r1-/- mice were purchased from Cyagen Biosciences.

Techniques: Cell Culture, Generated, Two Tailed Test

a , Thymus supernatants generated from female 1-2 mo C57BL/6 mice given SL-TBI (550 cGy), Dexamethasone (i.p., 20 mg/kg), Cyclophosphamide (i.p., 200 mg/kg) or LPS (i.p., 1.5 mg/kg) and mature Caspase-1 assayed by ELISA on days 0 (n = 4), 0.5 (n = 3), 1 (n = 3) and 3 (n = 3). b , Female 1-2 mo C57BL/6 WT (d0, n = 18; day 3, n = 15) or Il18 −/− (d0, n = 9; day 3, n = 8) and Il18r1 −/− (d0, n = 10; d3, n = 5) mice were given SL-TBI and thymus cellularity was assessed at baseline (day 0) or 3 days post-SL-TBI. c , Thymus supernatants generated from female 1-2 mo C57BL/6 WT (d0, n = 5; d1, n = 8; d3, n = 3) and Il18 −/− (n = 4/group) mice given SL-TBI (550 cGy) and Cortisol assayed by ELISA on days 0, 1 and 3. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for a using one-way ANOVA with Dunnet’s correction for multiple comparisons, b using Tukey’s correction for multiple comparisons, and for c using an unpaired two-tailed t-test. Panel a icons created with BioRender.com .

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , Thymus supernatants generated from female 1-2 mo C57BL/6 mice given SL-TBI (550 cGy), Dexamethasone (i.p., 20 mg/kg), Cyclophosphamide (i.p., 200 mg/kg) or LPS (i.p., 1.5 mg/kg) and mature Caspase-1 assayed by ELISA on days 0 (n = 4), 0.5 (n = 3), 1 (n = 3) and 3 (n = 3). b , Female 1-2 mo C57BL/6 WT (d0, n = 18; day 3, n = 15) or Il18 −/− (d0, n = 9; day 3, n = 8) and Il18r1 −/− (d0, n = 10; d3, n = 5) mice were given SL-TBI and thymus cellularity was assessed at baseline (day 0) or 3 days post-SL-TBI. c , Thymus supernatants generated from female 1-2 mo C57BL/6 WT (d0, n = 5; d1, n = 8; d3, n = 3) and Il18 −/− (n = 4/group) mice given SL-TBI (550 cGy) and Cortisol assayed by ELISA on days 0, 1 and 3. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for a using one-way ANOVA with Dunnet’s correction for multiple comparisons, b using Tukey’s correction for multiple comparisons, and for c using an unpaired two-tailed t-test. Panel a icons created with BioRender.com .

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Generated, Enzyme-linked Immunosorbent Assay, Two Tailed Test

a , b , Female 1- to 2-month-old C57/BL6 mice were administered SL-TBI (550 cGy), dexamethasone (intraperitoneal (i.p.) injection, 20 mg kg −1 ), cyclophosphamide (i.p., 200 mg kg −1 ) or LPS (i.p., 1.5 mg kg −1 ). a , Thymus cellularity (black) and cl-Cas-1 expression (red) were measured using fluorescently conjugated FAM-YVAD-FMK (a fluorescent probe that irreversibly binds and labels cl-Cas-1) in mice killed at baseline ( n = 15), day 0.5 ( n = 7), day 1 ( n = 8), day 3 ( n = 8), day 5 ( n = 4) and day 7 ( n = 4) after treatment; all statistics are compared to day 0. b , Amount of active IL-1β and active IL-18 in the thymus, measured by ELISA at the indicated time points after SL-TBI (IL-18: day 0, n = 9; day 0.5, n = 6; day 1, n = 6; day 3, n = 5; IL-1β: day 0, n = 4; day 0.5, n = 3; day 1, n = 3; day 3, n = 3), dexamethasone (i.p., 20 mg kg −1 ) (IL-18: day 0, n = 9; day 0.5, n = 3; day 1, n = 7; day 3, n = 6; IL-1β: day 0, n = 4; day 0.5, n = 3; day 1, n = 3; day 3, n = 3), cyclophosphamide (i.p., 200 mg kg −1 ) (IL-18: day 0, n = 5; day 1, n = 4; day 3, n = 4; IL-1β: day 0, n = 4; day 0.5, n = 3; day 1, n = 2; day 3, n = 3) or LPS (i.p., 1.5 mg kg −1 ) (IL-18: day 0, n = 9; day 0.5, n = 6; day 1, n = 6; day 3, n = 6; IL-1β: day 0, n = 3; day 0.5, n = 4; day 1, n = 3; day 3, n = 3); all statistics are compared to day 0. c , Amount of active IL-18 measured by ELISA in thymuses of female 1- to 2-month-old Cas1 Δ10 mice on day 0 ( n = 7) and day 1 ( n = 8) after SL-TBI. d , Amount of IL-18BP in thymuses of 1- to 2-month-old C57/BL6 WT mice on days 0, 1 and 3 after SL-TBI ( n = 3 per group). e , Ratio of active IL-18 to IL-18BP averaged on day 0 ( n = 9), day 1 ( n = 6) and day 3 ( n = 5) after SL-TBI, representing the amount of free active IL-18. f , Female 1- to 2-month-old C57/BL6 WT ( n = 18), Il1r1 −/− ( n = 3), Il18 −/− ( n = 7) and Il18r1 −/− ( n = 8) mice were exposed to SL-TBI, and thymus cellularity was measured 7 days later. g , Female 1- to 2-month-old C57/BL6 WT ( n = 7) or Cas1 Δ10 ( n = 8) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. h , Female 1- to 2-month-old C57/BL6 WT mice were exposed to SL-TBI and then administered PBS vehicle ( n = 12) or rIL-18 ( n = 10) on day 3 (subcutaneous (s.c.) injection, 2.5 mg kg −1 ); thymuses were isolated on day 7. i , Female 1- to 2-month-old C57BL/6 mice were lethally irradiated and transplanted (intravenous (i.v.) injection) with 5 × 10 6 CD45.1 + WT bone marrow hematopoietic cells. Recipient mice were treated with 200 μg of anti-IL-18 mAb ( n = 10) or equal-volume control (PBS) ( n = 11), and thymus cellularity was measured on day 50 following transplant. Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate; NS, not significant. Statistics were generated for a , b and d – f using one-way analysis of variance (ANOVA) with Dunnet’s correction for multiple comparisons and for c and g – i using unpaired two-tailed t tests. Panel a icons created with BioRender.com .

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , b , Female 1- to 2-month-old C57/BL6 mice were administered SL-TBI (550 cGy), dexamethasone (intraperitoneal (i.p.) injection, 20 mg kg −1 ), cyclophosphamide (i.p., 200 mg kg −1 ) or LPS (i.p., 1.5 mg kg −1 ). a , Thymus cellularity (black) and cl-Cas-1 expression (red) were measured using fluorescently conjugated FAM-YVAD-FMK (a fluorescent probe that irreversibly binds and labels cl-Cas-1) in mice killed at baseline ( n = 15), day 0.5 ( n = 7), day 1 ( n = 8), day 3 ( n = 8), day 5 ( n = 4) and day 7 ( n = 4) after treatment; all statistics are compared to day 0. b , Amount of active IL-1β and active IL-18 in the thymus, measured by ELISA at the indicated time points after SL-TBI (IL-18: day 0, n = 9; day 0.5, n = 6; day 1, n = 6; day 3, n = 5; IL-1β: day 0, n = 4; day 0.5, n = 3; day 1, n = 3; day 3, n = 3), dexamethasone (i.p., 20 mg kg −1 ) (IL-18: day 0, n = 9; day 0.5, n = 3; day 1, n = 7; day 3, n = 6; IL-1β: day 0, n = 4; day 0.5, n = 3; day 1, n = 3; day 3, n = 3), cyclophosphamide (i.p., 200 mg kg −1 ) (IL-18: day 0, n = 5; day 1, n = 4; day 3, n = 4; IL-1β: day 0, n = 4; day 0.5, n = 3; day 1, n = 2; day 3, n = 3) or LPS (i.p., 1.5 mg kg −1 ) (IL-18: day 0, n = 9; day 0.5, n = 6; day 1, n = 6; day 3, n = 6; IL-1β: day 0, n = 3; day 0.5, n = 4; day 1, n = 3; day 3, n = 3); all statistics are compared to day 0. c , Amount of active IL-18 measured by ELISA in thymuses of female 1- to 2-month-old Cas1 Δ10 mice on day 0 ( n = 7) and day 1 ( n = 8) after SL-TBI. d , Amount of IL-18BP in thymuses of 1- to 2-month-old C57/BL6 WT mice on days 0, 1 and 3 after SL-TBI ( n = 3 per group). e , Ratio of active IL-18 to IL-18BP averaged on day 0 ( n = 9), day 1 ( n = 6) and day 3 ( n = 5) after SL-TBI, representing the amount of free active IL-18. f , Female 1- to 2-month-old C57/BL6 WT ( n = 18), Il1r1 −/− ( n = 3), Il18 −/− ( n = 7) and Il18r1 −/− ( n = 8) mice were exposed to SL-TBI, and thymus cellularity was measured 7 days later. g , Female 1- to 2-month-old C57/BL6 WT ( n = 7) or Cas1 Δ10 ( n = 8) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. h , Female 1- to 2-month-old C57/BL6 WT mice were exposed to SL-TBI and then administered PBS vehicle ( n = 12) or rIL-18 ( n = 10) on day 3 (subcutaneous (s.c.) injection, 2.5 mg kg −1 ); thymuses were isolated on day 7. i , Female 1- to 2-month-old C57BL/6 mice were lethally irradiated and transplanted (intravenous (i.v.) injection) with 5 × 10 6 CD45.1 + WT bone marrow hematopoietic cells. Recipient mice were treated with 200 μg of anti-IL-18 mAb ( n = 10) or equal-volume control (PBS) ( n = 11), and thymus cellularity was measured on day 50 following transplant. Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate; NS, not significant. Statistics were generated for a , b and d – f using one-way analysis of variance (ANOVA) with Dunnet’s correction for multiple comparisons and for c and g – i using unpaired two-tailed t tests. Panel a icons created with BioRender.com .

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Injection, Expressing, Enzyme-linked Immunosorbent Assay, Isolation, Irradiation, Control, Generated, Two Tailed Test

a , Standard scaled dot plot of Il18r1 and Il18rap gene expression by population of cells from thymuses of female 1- to 2-month-old C57BL/6 mice at baseline, taken from the scRNAseq dataset described in Fig. . nmSC, nonmyelinating Schwann cells; mTEC prol , proliferating mTECs. b , Concatenated flow cytometry plots showing the expression of IL-18R in CD45 + NK1.1 + TCRβ + CD1d-αGalCer tetramer + (NKT1) and CD1d-αGalCer tetramer − (NKT2) invariant NK cells, CD45 + NK1.1 + TCRβ − CD49b + NK cells and CD45 + NK1.1 + TCRβ − CD49a + ILC1s ( n = 5 per group). Gates were based on expression in Il18r1 −/− mice. c , Percentage of IL-18R-expressing cTECs, mTECs, fibroblasts, endothelial cells, other CD45 − cells, early thymic progenitors (ETP), thymocytes (DN1–4, double-positive (DP), and single-positive CD4 + (SP4) and CD8 + (SP8) cells), T reg cells, γδ T cells, NK cells ( n = 9), ILC1s ( n = 4), ILC2s ( n = 4), ILC3s ( n = 4), cDC1s, cDC2s and macrophages ( n = 5 per group unless otherwise specified). d , Female 1- to 2-month-old Il18r1 fl/fl :Foxn1 -Cre − ( Il18r1 WT , n = 11) and Il18r1 fl/fl :Foxn1 -Cre + ( Il18r1 ΔTEC , n = 8) mice were exposed to SL-TBI, and thymus cellularity was assessed 7 days later. e , f , Bone marrow populations were measured for IL-18R expression ( n = 6 per group), shown as flow cytometry plots ( e ) and percentage of positive cells ( f ). LSK, lineage (Lin) − Sca-1 + c-Kit + cells; LT-HSC, long-term hematopoietic stem cells; ST-HSC, short-term hematopoietic stem cells; MMP2–4, multipotent progenitors. g , Female 1- to 2-month-old WT CD45.1 + mice were lethally irradiated and transplanted (i.v.) with 2.5 × 10 6 WT CD45.1 + bone marrow cells and 2.5 × 10 6 bone marrow cells from either CD45.2 + WT or Il18r1 −/− mice. h , Contribution of CD45.2 + cells in the thymus at 2 weeks following transplant ( n = 5 per group). i , Contribution of CD45.2 + cells to the total CD45 + cell (left) or T cell (right) reconstitution in peripheral blood over 17 weeks after transplantation (WT→WT n = 6; Il18r1 −/− →WT n = 8). j , k , At 17 weeks after transplantation, recipient mice were administered a subsequent dose of SL-TBI (550 cGy). Thymuses were collected after 7 days, and the percentage of CD45.2 + cells relative to all thymic CD45 + cells ( j ) and the total thymus cellularity ( k ) were measured (WT→WT: n = 6; Il18r1 −/− →WT: n = 8). Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for d , h , j and k using unpaired two-tailed t tests.

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , Standard scaled dot plot of Il18r1 and Il18rap gene expression by population of cells from thymuses of female 1- to 2-month-old C57BL/6 mice at baseline, taken from the scRNAseq dataset described in Fig. . nmSC, nonmyelinating Schwann cells; mTEC prol , proliferating mTECs. b , Concatenated flow cytometry plots showing the expression of IL-18R in CD45 + NK1.1 + TCRβ + CD1d-αGalCer tetramer + (NKT1) and CD1d-αGalCer tetramer − (NKT2) invariant NK cells, CD45 + NK1.1 + TCRβ − CD49b + NK cells and CD45 + NK1.1 + TCRβ − CD49a + ILC1s ( n = 5 per group). Gates were based on expression in Il18r1 −/− mice. c , Percentage of IL-18R-expressing cTECs, mTECs, fibroblasts, endothelial cells, other CD45 − cells, early thymic progenitors (ETP), thymocytes (DN1–4, double-positive (DP), and single-positive CD4 + (SP4) and CD8 + (SP8) cells), T reg cells, γδ T cells, NK cells ( n = 9), ILC1s ( n = 4), ILC2s ( n = 4), ILC3s ( n = 4), cDC1s, cDC2s and macrophages ( n = 5 per group unless otherwise specified). d , Female 1- to 2-month-old Il18r1 fl/fl :Foxn1 -Cre − ( Il18r1 WT , n = 11) and Il18r1 fl/fl :Foxn1 -Cre + ( Il18r1 ΔTEC , n = 8) mice were exposed to SL-TBI, and thymus cellularity was assessed 7 days later. e , f , Bone marrow populations were measured for IL-18R expression ( n = 6 per group), shown as flow cytometry plots ( e ) and percentage of positive cells ( f ). LSK, lineage (Lin) − Sca-1 + c-Kit + cells; LT-HSC, long-term hematopoietic stem cells; ST-HSC, short-term hematopoietic stem cells; MMP2–4, multipotent progenitors. g , Female 1- to 2-month-old WT CD45.1 + mice were lethally irradiated and transplanted (i.v.) with 2.5 × 10 6 WT CD45.1 + bone marrow cells and 2.5 × 10 6 bone marrow cells from either CD45.2 + WT or Il18r1 −/− mice. h , Contribution of CD45.2 + cells in the thymus at 2 weeks following transplant ( n = 5 per group). i , Contribution of CD45.2 + cells to the total CD45 + cell (left) or T cell (right) reconstitution in peripheral blood over 17 weeks after transplantation (WT→WT n = 6; Il18r1 −/− →WT n = 8). j , k , At 17 weeks after transplantation, recipient mice were administered a subsequent dose of SL-TBI (550 cGy). Thymuses were collected after 7 days, and the percentage of CD45.2 + cells relative to all thymic CD45 + cells ( j ) and the total thymus cellularity ( k ) were measured (WT→WT: n = 6; Il18r1 −/− →WT: n = 8). Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for d , h , j and k using unpaired two-tailed t tests.

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Gene Expression, Flow Cytometry, Expressing, Irradiation, Transplantation Assay, Generated, Two Tailed Test

IL-18R expression on thymic cellular populations (see Extended Data Fig. for gating) taken from female 1-2 mo C57BL/6 WT or Il18r1 −/− mice (n = 3-5/group).

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: IL-18R expression on thymic cellular populations (see Extended Data Fig. for gating) taken from female 1-2 mo C57BL/6 WT or Il18r1 −/− mice (n = 3-5/group).

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Expressing

a – c , 50,000 lineage depleted bone marrow cells were co-cultured with OP9-DLL1 GFP fibroblasts confluent in a 6-well dish with 5 ng/mL Flt3L plus 1 ng/mL IL-7 and 0, 1 or 10 ng/mL rIL-18 (n = 1/group). a , (Top) CD45 + Thy1 + CD4 − CD8 − DN1-4 thymocyte differentiation measured according to CD44 and CD25 expression 2 weeks post co-culture and (Bottom) CD45 + Thy1 + thymocyte differentiation into CD4 + CD8 + Double Positive population 3 weeks post co-culture. (Right) Ratio of DN2:DN1 thymocyte differentiation 2 weeks post co-culture. b , Thymocyte expansion measured by non-adherent cell count quantified 2 and 3 weeks post co-culture with OP9-DLL1 GFP adherent cells. c , 50,000 bone marrow CD45+ Lineage- cKit+ Sca-1+ LSKs were FACS purified and co-cultured with OP9-DLL1 GFP fibroblasts confluent in a 6-well dish with 5 ng/mL Ftl3L plus 1 ng/mL IL-7 and 0, 1 or 10 ng/mL rIL-18 (n = 4/group) and 10 days later, thymocyte expansion was quantified by measuring non-adherent cell expansion. d , Female 1-2 mo C57BL/6 mice were administered 200μg αNK1.1 monoclonal antibody or control PBS (i.p) at days -1, 1 and 3 days post SL-TBI and thymuses assessed at day 7. Thymus NK1.1 + IL-18R + (Left) and NKG2D + IL-18R + (Right) cells (parent gated on viable CD45 + CD4 − CD8 − cells) (n = 9/group). e , Female 1-2 mo C57BL/6 WT ( Cd1d +/+ ) and Cd1d −/− mice were given SL-TBI and thymus cellularity was measured 35 days later (n = 5/group). f , Female 1-2 mo Il18r1 fl/fl :Ncr1-Cre − ( Il18r1 WT , n = 5) and Il18r1 fl/fl :Ncr1-Cre + ( Il18r1 ΔNK/ILC1 , n = 6) mice were given SL-TBI and thymus cellularity measured on day 7 post SL-TBI. g , Female 1-2 mo l18r1 WT and Il18r1 ΔNK/ILC1 thymus CD45 + NK1.1 + TCRβ — CD49b + NK cells at baseline (n = 5/group). Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for e , f using unpaired two-tailed t-tests.

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a – c , 50,000 lineage depleted bone marrow cells were co-cultured with OP9-DLL1 GFP fibroblasts confluent in a 6-well dish with 5 ng/mL Flt3L plus 1 ng/mL IL-7 and 0, 1 or 10 ng/mL rIL-18 (n = 1/group). a , (Top) CD45 + Thy1 + CD4 − CD8 − DN1-4 thymocyte differentiation measured according to CD44 and CD25 expression 2 weeks post co-culture and (Bottom) CD45 + Thy1 + thymocyte differentiation into CD4 + CD8 + Double Positive population 3 weeks post co-culture. (Right) Ratio of DN2:DN1 thymocyte differentiation 2 weeks post co-culture. b , Thymocyte expansion measured by non-adherent cell count quantified 2 and 3 weeks post co-culture with OP9-DLL1 GFP adherent cells. c , 50,000 bone marrow CD45+ Lineage- cKit+ Sca-1+ LSKs were FACS purified and co-cultured with OP9-DLL1 GFP fibroblasts confluent in a 6-well dish with 5 ng/mL Ftl3L plus 1 ng/mL IL-7 and 0, 1 or 10 ng/mL rIL-18 (n = 4/group) and 10 days later, thymocyte expansion was quantified by measuring non-adherent cell expansion. d , Female 1-2 mo C57BL/6 mice were administered 200μg αNK1.1 monoclonal antibody or control PBS (i.p) at days -1, 1 and 3 days post SL-TBI and thymuses assessed at day 7. Thymus NK1.1 + IL-18R + (Left) and NKG2D + IL-18R + (Right) cells (parent gated on viable CD45 + CD4 − CD8 − cells) (n = 9/group). e , Female 1-2 mo C57BL/6 WT ( Cd1d +/+ ) and Cd1d −/− mice were given SL-TBI and thymus cellularity was measured 35 days later (n = 5/group). f , Female 1-2 mo Il18r1 fl/fl :Ncr1-Cre − ( Il18r1 WT , n = 5) and Il18r1 fl/fl :Ncr1-Cre + ( Il18r1 ΔNK/ILC1 , n = 6) mice were given SL-TBI and thymus cellularity measured on day 7 post SL-TBI. g , Female 1-2 mo l18r1 WT and Il18r1 ΔNK/ILC1 thymus CD45 + NK1.1 + TCRβ — CD49b + NK cells at baseline (n = 5/group). Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for e , f using unpaired two-tailed t-tests.

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Cell Culture, Expressing, Co-Culture Assay, Cell Counting, Purification, Control, Generated, Two Tailed Test

a , CellChat interaction analysis for IL-18 at baseline and following SL-TBI, taken from the scRNAseq dataset described in Fig. , with quantification of the aggregate signal strength for each IL-18 target cell. b – d , Female 1- to 2-month-old C57BL/6 CD45.2 + mice were lethally irradiated and transplanted (i.v.) with 5 × 10 6 WT CD45.1 + bone marrow cells. b , Concatenated flow cytometry plots showing CD45 + CD45.1 − CD4 − CD8 − cells (top) and CD45 + CD45.1 − CD4 − CD8 − NK1.1 + IL-18R + cells gated on CD3 + NKT cells and CD49b + NK cells (bottom) from thymus-recipient mice at the indicated time points after HCT ( n = 4–7 per time point). c , d , Proportion ( c ) and total number ( d ) of recipient NK or NKT cells before HCT (day 0; n = 7) and on days 1, 3, 7 and 14 after HCT ( n = 4 per group). e , Thymuses of female 1- to 2-month-old C57BL/6 mice were visualized at steady state or on day 3 or 7 after SL-TBI at 12×, assessing keratin-14-positive (Krt14 + ) mTECs (green), keratin-8-positive (Krt8 + ) cTECs (pink) and NKp46 + NK cells (arrows). The NKp46 + NK/ILC1 cell distribution within the thymus cortex or medulla at 0, 3 and 7 days after SL-TBI is shown ( n = 3 per group). f , Female 1- to 2-month-old WT C57BL/6 mice were administered 200 μg of anti-NK1.1 mAb or control PBS (i.p.) on days −1, 1 and 3 after SL-TBI, and thymus cellularity was assessed on day 7 ( n = 9 per group). g , Female 1- to 2-month-old C57BL/6 WT, Il18 −/− and Il18r1 −/− mice were administered 200 μg of anti-NK1.1 mAb or isotype/PBS (i.p.) as above. The relative change in thymus cellularity is shown, comparing control-treated (WT, n = 17; Il18 −/− , n = 9; Il18r1 −/− , n = 8) and anti-NK1.1 mAb-treated (WT, n = 21; Il18 −/− , n = 8; Il18r1 −/− , n = 9) mice within each strain 7 days after SL-TBI. h , Female 1- to 2-month-old C57BL/6 WT ( Cd1d +/+ , n = 9) and Cd1d −/− ( n = 6) mice were exposed to SL-TBI, and thymus cellularity was measured 7 days later. i , Female 1- to 2-month-old Il18r1 fl/fl :Lck -Cre − ( Il18r1 WT , n = 5) and Il18r1 fl/fl :Lck -Cre + ( Il18r1 ΔT/NKT , n = 5) mice were exposed to SL-TBI and administered rIL-18 (s.c., 2.5 mg kg −1 ) on day 3. Thymus cellularity was measured on day 7 after SL-TBI. j , Female 1- to 2-month-old Il18r1 fl/fl :Ncr1 -Cre − ( Il18r1 WT , n = 6) and Il18r1 fl/fl :Ncr1 -Cre + ( Il18r1 ΔNK/ILC1 , n = 7) mice were exposed to SL-TBI and administered rIL-18 (s.c., 2.5 mg kg −1 ) on day 3. Thymus cellularity was measured on day 7 after SL-TBI. Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for c and d using one-way ANOVA with Dunnet’s correction for multiple comparisons, for e using one-way ANOVA with Tukey’s correction for multiple comparisons, and for f – j using unpaired two-tailed t tests.

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , CellChat interaction analysis for IL-18 at baseline and following SL-TBI, taken from the scRNAseq dataset described in Fig. , with quantification of the aggregate signal strength for each IL-18 target cell. b – d , Female 1- to 2-month-old C57BL/6 CD45.2 + mice were lethally irradiated and transplanted (i.v.) with 5 × 10 6 WT CD45.1 + bone marrow cells. b , Concatenated flow cytometry plots showing CD45 + CD45.1 − CD4 − CD8 − cells (top) and CD45 + CD45.1 − CD4 − CD8 − NK1.1 + IL-18R + cells gated on CD3 + NKT cells and CD49b + NK cells (bottom) from thymus-recipient mice at the indicated time points after HCT ( n = 4–7 per time point). c , d , Proportion ( c ) and total number ( d ) of recipient NK or NKT cells before HCT (day 0; n = 7) and on days 1, 3, 7 and 14 after HCT ( n = 4 per group). e , Thymuses of female 1- to 2-month-old C57BL/6 mice were visualized at steady state or on day 3 or 7 after SL-TBI at 12×, assessing keratin-14-positive (Krt14 + ) mTECs (green), keratin-8-positive (Krt8 + ) cTECs (pink) and NKp46 + NK cells (arrows). The NKp46 + NK/ILC1 cell distribution within the thymus cortex or medulla at 0, 3 and 7 days after SL-TBI is shown ( n = 3 per group). f , Female 1- to 2-month-old WT C57BL/6 mice were administered 200 μg of anti-NK1.1 mAb or control PBS (i.p.) on days −1, 1 and 3 after SL-TBI, and thymus cellularity was assessed on day 7 ( n = 9 per group). g , Female 1- to 2-month-old C57BL/6 WT, Il18 −/− and Il18r1 −/− mice were administered 200 μg of anti-NK1.1 mAb or isotype/PBS (i.p.) as above. The relative change in thymus cellularity is shown, comparing control-treated (WT, n = 17; Il18 −/− , n = 9; Il18r1 −/− , n = 8) and anti-NK1.1 mAb-treated (WT, n = 21; Il18 −/− , n = 8; Il18r1 −/− , n = 9) mice within each strain 7 days after SL-TBI. h , Female 1- to 2-month-old C57BL/6 WT ( Cd1d +/+ , n = 9) and Cd1d −/− ( n = 6) mice were exposed to SL-TBI, and thymus cellularity was measured 7 days later. i , Female 1- to 2-month-old Il18r1 fl/fl :Lck -Cre − ( Il18r1 WT , n = 5) and Il18r1 fl/fl :Lck -Cre + ( Il18r1 ΔT/NKT , n = 5) mice were exposed to SL-TBI and administered rIL-18 (s.c., 2.5 mg kg −1 ) on day 3. Thymus cellularity was measured on day 7 after SL-TBI. j , Female 1- to 2-month-old Il18r1 fl/fl :Ncr1 -Cre − ( Il18r1 WT , n = 6) and Il18r1 fl/fl :Ncr1 -Cre + ( Il18r1 ΔNK/ILC1 , n = 7) mice were exposed to SL-TBI and administered rIL-18 (s.c., 2.5 mg kg −1 ) on day 3. Thymus cellularity was measured on day 7 after SL-TBI. Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for c and d using one-way ANOVA with Dunnet’s correction for multiple comparisons, for e using one-way ANOVA with Tukey’s correction for multiple comparisons, and for f – j using unpaired two-tailed t tests.

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Irradiation, Flow Cytometry, Control, Generated, Two Tailed Test

a , Normalized gene expression in NK/ILC1 or NKT cells of the cytotoxicity factors Ifng , Prf1 , Gzma and Gzmb , as well as the activation markers Nkg7 , Klrd1 , Klrk1, Ncr1 , Klrc2 and Klra4 , on days 0, 1, 4 and 7 after SL-TBI, taken from the scRNAseq dataset described in Fig. . b , Concatenated flow cytometry plots and corresponding geometric mean fluorescence intensity (gMFI) of CD45 + NK1.1 + TCRβ − NK cell expression of Ifng -GFP (day 0, n = 4; day 3, n = 5), perforin (day 0, n = 6; day 3, n = 9) and granzyme B (GZMB; day 0, n = 4; day 3, n = 5) on days 0 and 3 following SL-TBI in female 1- to 2-month-old C57BL/6 WT or Ifng -reporter mice. c , Amount of thymic IFNγ (day 0, n = 8; day 3, n = 3), perforin ( n = 8 per group) and granzyme B ( n = 8 per group) measured by ELISA in female 1- to 2-month-old C57BL/6 mice on days 0 and 3 after SL-TBI. d , Thymuses were collected from female 1- to 2-month-old C57BL/6 mice on day 3 after SL-TBI. Concatenated flow cytometry plots gated on all CD45 + Ifng -GFP (left), CD45 + perforin + (middle) and CD45 + GZMB + (right) cells, as well as the total thymus cellularity of Ifng -GFP (left; day 0, n = 3; day 3, n = 4), perforin + (middle; day 0, n = 3; day 3, n = 7) and GZMB + (right; day 0, n = 3; day 3, n = 7) CD45 + NK1.1 + TCRβ − CD49b + NK cells, CD45 + NK1.1 + TCRβ − CD49a + ILC1s, CD45 + NK1.1 + TCRβ + CD49b − NKT cells and CD45 + TCRβ + NK1.1 − T cells, are shown. e , Gene expression heat map of thymic NK/ILC1 and NKT cells for Gzma , Gzmb , Prf1 , Ifng , Nkg7 , Klrk1 , Ncr1 , Klrd1 and Il18r1 at 1, 4 and 7 days following SL-TBI. Each column represents a cell, with the cells ordered based on the expression of Il18rap (in ascending order from left to right). The time after TBI is indicated by the colors at the bottom. f , NK1.1 + IL-18R + TCRβ − CD49b + NK cells from female 1- to 2-month-old C57BL/6 mice were purified using FACS at baseline (d0) or 2 days after SL-TBI (d2) and cocultured with CellTrace-labeled RMA-S target cells at a 2:1 effector-to-target ratio. RMA-S target cell Annexin V expression was measured 5 h after coculture, and cell death was assessed ( n = 4 biological replicates per group, representative of three independent experiments). Dashed lines represent RMA-S alone (bottom) or the positive control (top). Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for b – d and f using unpaired two-tailed t tests.

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , Normalized gene expression in NK/ILC1 or NKT cells of the cytotoxicity factors Ifng , Prf1 , Gzma and Gzmb , as well as the activation markers Nkg7 , Klrd1 , Klrk1, Ncr1 , Klrc2 and Klra4 , on days 0, 1, 4 and 7 after SL-TBI, taken from the scRNAseq dataset described in Fig. . b , Concatenated flow cytometry plots and corresponding geometric mean fluorescence intensity (gMFI) of CD45 + NK1.1 + TCRβ − NK cell expression of Ifng -GFP (day 0, n = 4; day 3, n = 5), perforin (day 0, n = 6; day 3, n = 9) and granzyme B (GZMB; day 0, n = 4; day 3, n = 5) on days 0 and 3 following SL-TBI in female 1- to 2-month-old C57BL/6 WT or Ifng -reporter mice. c , Amount of thymic IFNγ (day 0, n = 8; day 3, n = 3), perforin ( n = 8 per group) and granzyme B ( n = 8 per group) measured by ELISA in female 1- to 2-month-old C57BL/6 mice on days 0 and 3 after SL-TBI. d , Thymuses were collected from female 1- to 2-month-old C57BL/6 mice on day 3 after SL-TBI. Concatenated flow cytometry plots gated on all CD45 + Ifng -GFP (left), CD45 + perforin + (middle) and CD45 + GZMB + (right) cells, as well as the total thymus cellularity of Ifng -GFP (left; day 0, n = 3; day 3, n = 4), perforin + (middle; day 0, n = 3; day 3, n = 7) and GZMB + (right; day 0, n = 3; day 3, n = 7) CD45 + NK1.1 + TCRβ − CD49b + NK cells, CD45 + NK1.1 + TCRβ − CD49a + ILC1s, CD45 + NK1.1 + TCRβ + CD49b − NKT cells and CD45 + TCRβ + NK1.1 − T cells, are shown. e , Gene expression heat map of thymic NK/ILC1 and NKT cells for Gzma , Gzmb , Prf1 , Ifng , Nkg7 , Klrk1 , Ncr1 , Klrd1 and Il18r1 at 1, 4 and 7 days following SL-TBI. Each column represents a cell, with the cells ordered based on the expression of Il18rap (in ascending order from left to right). The time after TBI is indicated by the colors at the bottom. f , NK1.1 + IL-18R + TCRβ − CD49b + NK cells from female 1- to 2-month-old C57BL/6 mice were purified using FACS at baseline (d0) or 2 days after SL-TBI (d2) and cocultured with CellTrace-labeled RMA-S target cells at a 2:1 effector-to-target ratio. RMA-S target cell Annexin V expression was measured 5 h after coculture, and cell death was assessed ( n = 4 biological replicates per group, representative of three independent experiments). Dashed lines represent RMA-S alone (bottom) or the positive control (top). Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for b – d and f using unpaired two-tailed t tests.

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Gene Expression, Activation Assay, Flow Cytometry, Fluorescence, Expressing, Enzyme-linked Immunosorbent Assay, Purification, Labeling, Positive Control, Generated, Two Tailed Test

a , Taken from scRNAseq described in from Fig. : integrated UMAP showing undamaged, baseline thymus major clusters and annotations (left) and heatmap expression Ncr1, Itga1 and Itga1 . b , Number of NK cells at day 3 in WT or Il18r1 −/− mice (n = 5/group). c , d , Female C57BL/6 CD45.1 + and CD45.2 + mice were surgically conjoined to establish parabiotic pairs when both members of the pair received sublethal total body irradiation (SL-TBI; 550 cGy). Intrathymic/extrathymic chimerism was calculated on days 0, 1, 4, or 7 days after SL-TBI using congenic markers (CD45.1 and CD45.2) to determine mouse of origin (that is, cells expressing the same CD45 isoform as assessed mouse pair thymus = “intrathymic”; cells expressing the alternate isoform = “extrathymic”-derived). Absolute chimerism ( c ) (n = 8/group) and fold-change in NK cell number ( d ) across timepoints (d1, n = 6; d4, n = 6; d7, n = 8). e , Concatenated flow cytometry plots shown of NKG2D expression on CD45 + NK1.1 + TCRβ — CD49b + NK cells and gMFI of NKG2D expression of IL-18R − and IL-18R + NK cells at day 3 post SL-TBI (n = 3/group). f – h , Female 1-2 mo C57BL/6 WT (-rIL-18, n = 6; +rIL-18, n = 4) or Ifng -reporter (-rIL-18, n = 5; +rIL-18, n = 3) mice were given rIL-18 (s.c., 2.5 mg/kg) or PBS. f , Total thymus cellularity assessed on day 3. g – h , Expression of Ifng -GFP ( g ) or Perforin ( h ) at day 3. i , Female 1-2mo C57BL/6 mice were given SL-TBI and 3 days later administered with rIL-18 (s.c., 2.5 mg/kg, n = 3) or PBS (n = 4) as in Fig. . On day 7 NK1.1 + IL-18R + TCRβ − CD49b + NK cells were then FACS purified and cocultured with cell-dye labeled RMA-S target cells at a 5:1 Effector to Target ratio. RMA-S target cell Annexin V expression was measured 5 h post co-culture. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for b – d and f – i using unpaired two-tailed t-tests, e using paired two-tailed t-tests, and for c using one-way ANOVA with Dunnet’s correction for multiple comparisons.

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , Taken from scRNAseq described in from Fig. : integrated UMAP showing undamaged, baseline thymus major clusters and annotations (left) and heatmap expression Ncr1, Itga1 and Itga1 . b , Number of NK cells at day 3 in WT or Il18r1 −/− mice (n = 5/group). c , d , Female C57BL/6 CD45.1 + and CD45.2 + mice were surgically conjoined to establish parabiotic pairs when both members of the pair received sublethal total body irradiation (SL-TBI; 550 cGy). Intrathymic/extrathymic chimerism was calculated on days 0, 1, 4, or 7 days after SL-TBI using congenic markers (CD45.1 and CD45.2) to determine mouse of origin (that is, cells expressing the same CD45 isoform as assessed mouse pair thymus = “intrathymic”; cells expressing the alternate isoform = “extrathymic”-derived). Absolute chimerism ( c ) (n = 8/group) and fold-change in NK cell number ( d ) across timepoints (d1, n = 6; d4, n = 6; d7, n = 8). e , Concatenated flow cytometry plots shown of NKG2D expression on CD45 + NK1.1 + TCRβ — CD49b + NK cells and gMFI of NKG2D expression of IL-18R − and IL-18R + NK cells at day 3 post SL-TBI (n = 3/group). f – h , Female 1-2 mo C57BL/6 WT (-rIL-18, n = 6; +rIL-18, n = 4) or Ifng -reporter (-rIL-18, n = 5; +rIL-18, n = 3) mice were given rIL-18 (s.c., 2.5 mg/kg) or PBS. f , Total thymus cellularity assessed on day 3. g – h , Expression of Ifng -GFP ( g ) or Perforin ( h ) at day 3. i , Female 1-2mo C57BL/6 mice were given SL-TBI and 3 days later administered with rIL-18 (s.c., 2.5 mg/kg, n = 3) or PBS (n = 4) as in Fig. . On day 7 NK1.1 + IL-18R + TCRβ − CD49b + NK cells were then FACS purified and cocultured with cell-dye labeled RMA-S target cells at a 5:1 Effector to Target ratio. RMA-S target cell Annexin V expression was measured 5 h post co-culture. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for b – d and f – i using unpaired two-tailed t-tests, e using paired two-tailed t-tests, and for c using one-way ANOVA with Dunnet’s correction for multiple comparisons.

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Expressing, Irradiation, Derivative Assay, Flow Cytometry, Purification, Labeling, Co-Culture Assay, Generated, Two Tailed Test

a , b , Female 1- to 2-month-old C57BL/6 WT or Ifng -reporter mice were exposed to SL-TBI, and thymuses were collected on days 0 and 3 after irradiation. IL-18R + and IL-18R lo–neg CD45 + NK1.1 + TCRβ − CD49b + NK cells, CD45 + NK1.1 + TCRβ − CD49a + ILC1s and CD45 + NK1.1 + TCRβ + CD49b − NKT cells were compared. a , NK, ILC1 and NKT cellularity on day 0 ( n = 3) and day 3 ( n = 7) after SL-TBI. b , Fold change in NK cells ( n = 10), ILC1s ( n = 10) and NKT cells ( n = 7) between days 0 and 3 after SL-TBI. c , Female C57BL/6 CD45.1 + and CD45.2 + mice were surgically conjoined to establish parabiotic pairs when both members of the pair were subjected to SL-TBI. Thymuses were collected, and chimerism was calculated on day 0 ( n = 8), day 1 ( n = 6), day 4 ( n = 4) or day 7 ( n = 8) after SL-TBI. Congenic markers (CD45.1 and CD45.2) were used to determine the mouse of origin (that is, cells expressing the same CD45 isoform as the mouse-pair thymus were classified as ‘intrathymically’ derived, while cells expressing the alternate isoform were considered ‘extrathymically’ derived). The numbers of intrathymic or extrathymic CD45 + NK1.1 + CD3 − NK/ILC1 cells at the indicated time points are shown graphically. d , Concatenated flow cytometry plots showing Ifng -GFP, perforin and granzyme B expression within CD45 + NK1.1 + TCRβ − CD49b + NK cells. The gMFI of Ifng -GFP, perforin and granzyme B expression in IL-18R lo–neg and IL-18R + NK cells on day 3 after SL-TBI ( n = 8 per group) is shown. e , Female 1- to 2-month-old C57BL/6 WT or Il18r1 −/− mice were exposed to SL-TBI, and thymuses were isolated 3 days later. Concatenated flow cytometry plots and gMFI of perforin expression within CD45 + NK1.1 + TCRβ − CD49b + NK cells are shown ( n = 5 per group). f , Female 1- to 2-month-old Il18r1 fl/fl :Ncr1 -Cre − ( Il18r1 WT , n = 8) and Il18r1 fl/fl :Ncr1 -Cre + ( Il18r1 ΔNK/ILC1 , n = 9) mice were exposed to SL-TBI, and the total thymic IFNγ and perforin levels were measured 3 days later. g , Ifngr1 and Ifngr2 expression at baseline, taken from the scRNAseq dataset described in Fig. . h , Female 1- to 2-month-old C57BL/6 Ifngr fl/fl :Foxn1 -Cre − ( Ifngr WT , n = 6) and Ifngr fl/fl :Foxn1 -Cre + ( Ifngr ΔTEC , n = 9) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. i , Female 1- to 2-month-old C57BL/6 WT ( Ifngr +/+ , n = 10) or Ifngr1 −/− ( n = 7) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. j , Female 1- to 2-month-old C57BL/6 WT ( Prf +/+ , n = 10 and Gzmb +/+ , n = 5), Prf −/− ( n = 7) and Gzmb −/− ( n = 4) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for a , e , f and h – j using unpaired two-tailed t tests, for b and d using paired two-tailed t tests, and for c using one-way ANOVA with Dunnet’s correction for multiple comparisons. Panel c created with BioRender.com .

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , b , Female 1- to 2-month-old C57BL/6 WT or Ifng -reporter mice were exposed to SL-TBI, and thymuses were collected on days 0 and 3 after irradiation. IL-18R + and IL-18R lo–neg CD45 + NK1.1 + TCRβ − CD49b + NK cells, CD45 + NK1.1 + TCRβ − CD49a + ILC1s and CD45 + NK1.1 + TCRβ + CD49b − NKT cells were compared. a , NK, ILC1 and NKT cellularity on day 0 ( n = 3) and day 3 ( n = 7) after SL-TBI. b , Fold change in NK cells ( n = 10), ILC1s ( n = 10) and NKT cells ( n = 7) between days 0 and 3 after SL-TBI. c , Female C57BL/6 CD45.1 + and CD45.2 + mice were surgically conjoined to establish parabiotic pairs when both members of the pair were subjected to SL-TBI. Thymuses were collected, and chimerism was calculated on day 0 ( n = 8), day 1 ( n = 6), day 4 ( n = 4) or day 7 ( n = 8) after SL-TBI. Congenic markers (CD45.1 and CD45.2) were used to determine the mouse of origin (that is, cells expressing the same CD45 isoform as the mouse-pair thymus were classified as ‘intrathymically’ derived, while cells expressing the alternate isoform were considered ‘extrathymically’ derived). The numbers of intrathymic or extrathymic CD45 + NK1.1 + CD3 − NK/ILC1 cells at the indicated time points are shown graphically. d , Concatenated flow cytometry plots showing Ifng -GFP, perforin and granzyme B expression within CD45 + NK1.1 + TCRβ − CD49b + NK cells. The gMFI of Ifng -GFP, perforin and granzyme B expression in IL-18R lo–neg and IL-18R + NK cells on day 3 after SL-TBI ( n = 8 per group) is shown. e , Female 1- to 2-month-old C57BL/6 WT or Il18r1 −/− mice were exposed to SL-TBI, and thymuses were isolated 3 days later. Concatenated flow cytometry plots and gMFI of perforin expression within CD45 + NK1.1 + TCRβ − CD49b + NK cells are shown ( n = 5 per group). f , Female 1- to 2-month-old Il18r1 fl/fl :Ncr1 -Cre − ( Il18r1 WT , n = 8) and Il18r1 fl/fl :Ncr1 -Cre + ( Il18r1 ΔNK/ILC1 , n = 9) mice were exposed to SL-TBI, and the total thymic IFNγ and perforin levels were measured 3 days later. g , Ifngr1 and Ifngr2 expression at baseline, taken from the scRNAseq dataset described in Fig. . h , Female 1- to 2-month-old C57BL/6 Ifngr fl/fl :Foxn1 -Cre − ( Ifngr WT , n = 6) and Ifngr fl/fl :Foxn1 -Cre + ( Ifngr ΔTEC , n = 9) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. i , Female 1- to 2-month-old C57BL/6 WT ( Ifngr +/+ , n = 10) or Ifngr1 −/− ( n = 7) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. j , Female 1- to 2-month-old C57BL/6 WT ( Prf +/+ , n = 10 and Gzmb +/+ , n = 5), Prf −/− ( n = 7) and Gzmb −/− ( n = 4) mice were exposed to SL-TBI, and thymus cellularity was measured on day 7. Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for a , e , f and h – j using unpaired two-tailed t tests, for b and d using paired two-tailed t tests, and for c using one-way ANOVA with Dunnet’s correction for multiple comparisons. Panel c created with BioRender.com .

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Irradiation, Expressing, Derivative Assay, Flow Cytometry, Isolation, Generated, Two Tailed Test

a , Female 1-2 mo C57BL/6 mice were given SL-TBI and thymuses collected 0 and 3 days later. Concatenated flow plots showing H2kb expression of early thymic progenitors (ETPs), DN2-4, DP, SP4, SP8 cDC1, cDC2 cells (see Extended Data Fig. for gating) and CD45 + CD11b + Tim-4 + Macrophages and their respective gMFI 0 and 3 days post SL-TBI (n = 5/group). b , Female 1-2mo C57BL/6 mice were given SL-TBI and thymuses collected 3 days later and enriched for non-hematopoietic stromal cells which were cultured with or without poly(I:C) stimulated NK cells. Annexin V and 7-AAD expression of CD45 − EpCAM − MHC-II − non-TECs was measured at 5 h post co-culture (n = 4/group). c , Female 1-2 mo C57BL/6 WT (n = 5) or Il18r1 −/− (n = 6) thymuses collected at baseline and Annexin V and 7-AAD expression of cTECs and mTECs assessed. d, Female 1-2 mo C57BL/6 WT (n = 10) or Il18r1 −/− (n = 9) were given SL-TBI and thymuses collected at 5 days later. Annexin V and 7-AAD expression of CD45 − EpCAM − MHC-II − non-TECs was measured. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for a – d using unpaired two-tailed t-tests.

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , Female 1-2 mo C57BL/6 mice were given SL-TBI and thymuses collected 0 and 3 days later. Concatenated flow plots showing H2kb expression of early thymic progenitors (ETPs), DN2-4, DP, SP4, SP8 cDC1, cDC2 cells (see Extended Data Fig. for gating) and CD45 + CD11b + Tim-4 + Macrophages and their respective gMFI 0 and 3 days post SL-TBI (n = 5/group). b , Female 1-2mo C57BL/6 mice were given SL-TBI and thymuses collected 3 days later and enriched for non-hematopoietic stromal cells which were cultured with or without poly(I:C) stimulated NK cells. Annexin V and 7-AAD expression of CD45 − EpCAM − MHC-II − non-TECs was measured at 5 h post co-culture (n = 4/group). c , Female 1-2 mo C57BL/6 WT (n = 5) or Il18r1 −/− (n = 6) thymuses collected at baseline and Annexin V and 7-AAD expression of cTECs and mTECs assessed. d, Female 1-2 mo C57BL/6 WT (n = 10) or Il18r1 −/− (n = 9) were given SL-TBI and thymuses collected at 5 days later. Annexin V and 7-AAD expression of CD45 − EpCAM − MHC-II − non-TECs was measured. Graphs represent mean ± SEM; each dot represents an individual biological replicate; ns = not significant. Statistics were generated for a – d using unpaired two-tailed t-tests.

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Expressing, Cell Culture, Co-Culture Assay, Generated, Two Tailed Test

a , Normalized expression of the MHC-I genes H2-D1 , H2-K1 and B2 m following SL-TBI, taken from the scRNAseq dataset described in Fig. . Red box highlights epithelial populations. b , Thymuses from female 1- to 2-month-old C57BL/6 mice were collected at baseline ( n = 4) or 3 days after SL-TBI ( n = 5). Concatenated flow cytometry plots showing H-2K b expression in stromal subsets (gating and phenotypes are provided in Extended Data Fig. ) and the CD45 + population ( n = 10) are presented. c , Thymuses from female 1- to 2-month-old C57BL/6 mice were collected at baseline or 3 days after SL-TBI. Concatenated flow cytometry plots and quantification of RAE-1 expression in stromal subsets ( n = 5 per group) are shown. d , Female 1- to 2-month-old C57BL/6 mice were exposed to SL-TBI, and thymuses were collected 3 days later and enriched for nonhematopoietic stromal cells, which were cultured with or without poly(I:C)-stimulated NK cells. The expression of Annexin V (AnnV) and 7-aminoactinomycin D (7-AAD) in CD45 − EpCAM + MHC-II + Ly51 + cTECs and CD45 − EpCAM + MHC-II + UEA-1 + mTECs was measured 5 h after coculture ( n = 4 per group). e , Female 1- to 2-month-old C57BL/6 WT ( n = 14) or Il18r1 −/− ( n = 15) mice were exposed to SL-TBI. The expression of Annexin V and 7-AAD in CD45 − EpCAM + MHC-II + Ly51 + cTECs, CD45 − EpCAM + MHC-II + UEA-1 + mTECs was measured 5 days later. f , Female 1- to 2-month-old C57BL/6 WT or Il18r1 −/− mice were exposed to SL-TBI, and CD45 − EpCAM + MHC-II + Ly51 + cTEC and CD45 − EpCAM + MHC-II + UEA-1 + mTEC cellularity was measured 3 days later ( n = 5 biological replicates per group, representative of two independent experiments). g , Data extrapolated from the images in Fig. . The distance between NKp46 + cells and either keratin-14 + mTECs or keratin-8 + cTECs was estimated by nearest-neighbor analysis and shown as a waterfall plot (day 0, n = 278; day 3, n = 1,663; day 7, n = 426). Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for b – f using unpaired two-tailed t tests and for g using one-way ANOVA with Tukey’s correction for multiple comparisons.

Journal: Nature Immunology

Article Title: Damage-induced IL-18 stimulates thymic NK cells limiting endogenous tissue regeneration

doi: 10.1038/s41590-025-02270-z

Figure Lengend Snippet: a , Normalized expression of the MHC-I genes H2-D1 , H2-K1 and B2 m following SL-TBI, taken from the scRNAseq dataset described in Fig. . Red box highlights epithelial populations. b , Thymuses from female 1- to 2-month-old C57BL/6 mice were collected at baseline ( n = 4) or 3 days after SL-TBI ( n = 5). Concatenated flow cytometry plots showing H-2K b expression in stromal subsets (gating and phenotypes are provided in Extended Data Fig. ) and the CD45 + population ( n = 10) are presented. c , Thymuses from female 1- to 2-month-old C57BL/6 mice were collected at baseline or 3 days after SL-TBI. Concatenated flow cytometry plots and quantification of RAE-1 expression in stromal subsets ( n = 5 per group) are shown. d , Female 1- to 2-month-old C57BL/6 mice were exposed to SL-TBI, and thymuses were collected 3 days later and enriched for nonhematopoietic stromal cells, which were cultured with or without poly(I:C)-stimulated NK cells. The expression of Annexin V (AnnV) and 7-aminoactinomycin D (7-AAD) in CD45 − EpCAM + MHC-II + Ly51 + cTECs and CD45 − EpCAM + MHC-II + UEA-1 + mTECs was measured 5 h after coculture ( n = 4 per group). e , Female 1- to 2-month-old C57BL/6 WT ( n = 14) or Il18r1 −/− ( n = 15) mice were exposed to SL-TBI. The expression of Annexin V and 7-AAD in CD45 − EpCAM + MHC-II + Ly51 + cTECs, CD45 − EpCAM + MHC-II + UEA-1 + mTECs was measured 5 days later. f , Female 1- to 2-month-old C57BL/6 WT or Il18r1 −/− mice were exposed to SL-TBI, and CD45 − EpCAM + MHC-II + Ly51 + cTEC and CD45 − EpCAM + MHC-II + UEA-1 + mTEC cellularity was measured 3 days later ( n = 5 biological replicates per group, representative of two independent experiments). g , Data extrapolated from the images in Fig. . The distance between NKp46 + cells and either keratin-14 + mTECs or keratin-8 + cTECs was estimated by nearest-neighbor analysis and shown as a waterfall plot (day 0, n = 278; day 3, n = 1,663; day 7, n = 426). Graphs represent mean ± s.e.m.; each dot represents an individual biological replicate. Statistics were generated for b – f using unpaired two-tailed t tests and for g using one-way ANOVA with Tukey’s correction for multiple comparisons.

Article Snippet: Il18r1 fl/fl mice were obtained from G. Trinchieri (National Cancer Institute) and crossed with Foxn1 -Cre + mice obtained from The Jackson Laboratory (018448) and Ncr1 -Cre + mice obtained from K. Barry (Fred Hutchinson Cancer Center) to generate Il18r1 fl/fl : Foxn1 -Cre + ( Il18r1 ΔTEC ) and Il18r1 fl/fl : Ncr1 -Cre + ( Il18r1 ΔNK ) mice, respectively.

Techniques: Expressing, Flow Cytometry, Cell Culture, Generated, Two Tailed Test

Identification of IL17RB, IL18R1, and IL22RA2 as potential targets of miR-155-5p. IL17RB, IL18R1, and IL22RA2 were identified as potential targets of miR-155-5p by the databases (a); this was confirmed by the dual-luciferase report assay (b). The levels of IL17RB, IL18R1, and IL22RA2 were measured by qRT-PCR (c). *p < 0.05 and **p < 0.01, ANOVA.

Journal: Bioengineered

Article Title: MicroRNA-155-5p modulates the progression of acute respiratory distress syndrome by targeting interleukin receptors

doi: 10.1080/21655979.2022.2071020

Figure Lengend Snippet: Identification of IL17RB, IL18R1, and IL22RA2 as potential targets of miR-155-5p. IL17RB, IL18R1, and IL22RA2 were identified as potential targets of miR-155-5p by the databases (a); this was confirmed by the dual-luciferase report assay (b). The levels of IL17RB, IL18R1, and IL22RA2 were measured by qRT-PCR (c). *p < 0.05 and **p < 0.01, ANOVA.

Article Snippet: In brief, LPS reagent was injected into the medium for 24 hours and the relative levels of human IL17RB (EK0785), IL18R1 (EK1260), IL22RA2, IL-1β, IL-6, IL-8, and TNF-α were measured in the treated cells using an ELISA kit (Boster, Wuhan, China) in accordance with the manufacturer’s protocol [ ].

Techniques: Luciferase, Quantitative RT-PCR

Upregulated levels of the inflammatory cytokines in patients with ARDS. The levels of IL17RB, IL18R1, and IL22RA2 in serum samples from patients with ARDS (a). Serum concentrations of IL17RB, IL18R1, and IL22RA2 (b), and IL-1β, IL-6, IL-8, and TNF-α (c) in patients with ARDS were analyzed by ELISA. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control.

Journal: Bioengineered

Article Title: MicroRNA-155-5p modulates the progression of acute respiratory distress syndrome by targeting interleukin receptors

doi: 10.1080/21655979.2022.2071020

Figure Lengend Snippet: Upregulated levels of the inflammatory cytokines in patients with ARDS. The levels of IL17RB, IL18R1, and IL22RA2 in serum samples from patients with ARDS (a). Serum concentrations of IL17RB, IL18R1, and IL22RA2 (b), and IL-1β, IL-6, IL-8, and TNF-α (c) in patients with ARDS were analyzed by ELISA. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control.

Article Snippet: In brief, LPS reagent was injected into the medium for 24 hours and the relative levels of human IL17RB (EK0785), IL18R1 (EK1260), IL22RA2, IL-1β, IL-6, IL-8, and TNF-α were measured in the treated cells using an ELISA kit (Boster, Wuhan, China) in accordance with the manufacturer’s protocol [ ].

Techniques: Enzyme-linked Immunosorbent Assay, Control

miR-155-5p inhibited the NF-kB signaling pathway. The expression levels of the inflammatory cytokine receptors (IL17RB, IL18R1, and IL22R2) and NF-kB-related proteins (NF-kB, STAT1, and STAT3) were measured by western blotting analysis with β-actin used as the internal control. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control.

Journal: Bioengineered

Article Title: MicroRNA-155-5p modulates the progression of acute respiratory distress syndrome by targeting interleukin receptors

doi: 10.1080/21655979.2022.2071020

Figure Lengend Snippet: miR-155-5p inhibited the NF-kB signaling pathway. The expression levels of the inflammatory cytokine receptors (IL17RB, IL18R1, and IL22R2) and NF-kB-related proteins (NF-kB, STAT1, and STAT3) were measured by western blotting analysis with β-actin used as the internal control. *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control.

Article Snippet: In brief, LPS reagent was injected into the medium for 24 hours and the relative levels of human IL17RB (EK0785), IL18R1 (EK1260), IL22RA2, IL-1β, IL-6, IL-8, and TNF-α were measured in the treated cells using an ELISA kit (Boster, Wuhan, China) in accordance with the manufacturer’s protocol [ ].

Techniques: Expressing, Western Blot, Control